Neonatal Anemia in Preterm Infants: Are We Overtransfusing?
- PMID: 40786382
- PMCID: PMC12335185
- DOI: 10.7759/cureus.87657
Neonatal Anemia in Preterm Infants: Are We Overtransfusing?
Abstract
Aims and objectives: The purpose of this study was to ascertain the appropriate packed red blood cell transfusion (PRBCT) practice for preterm infants consistent with multiple international guidelines.
Method: This retrospective study was conducted at a tertiary care center in India from February 2019 to December 2020. All preterm neonates born at <32 weeks of gestation who received PRBCTs during the study period were included. The hemoglobin (Hb) levels at the time of transfusion were analyzed to assess adherence to the transfusion thresholds recommended by the British Committee for Standards in Haematology (BCSH), Canadian Blood Services (CBS), and the Australian National Blood Authority (ANBA), considering postnatal age and the need for respiratory support.
Results: A total of 43 preterm neonates (gestational age, 28.08±1.08 weeks; birth weight, 1,018±0.027 g) received 78 PRBCTs. Specifically, nine (11.5%) PRBCTs were given in the first week, 14 (18%) in the second week, and 55 (70.5%) at three or more weeks of age. Further, nine (11.5%) PRBCTs were given during mechanical ventilation (MV), 49 (63%) with non-invasive ventilation (NIV) or oxygen (O₂) support, and 20 (25.5%) without O₂ support. The appropriateness of all of the PRBCTs per the BCSH, CBS, and ANBA guidelines was 63/78 (80.7%), 58/78 (74.3%), and 78/78 (100%), respectively. Most of the neonates on respiratory support received PRBCTs in a manner consistent with the CBS, BCSH, and ANBA guidelines, whereas most of the neonates not on oxygen (O₂) therapy received PRBCTs for late anemia (at three weeks or more of age) at a higher Hb level than that suggested by the CBS and BCSH guidelines but consistent with the ANBA guidelines.
Conclusion: In this transfusion audit study, liberal PRBCT practice was observed for late anemia among stable preterm infants, consistent with the CBS and BCSH blood transfusion guidelines. Hence, there is room for improvement in PRBCT policies in terms of quality-improvement interventions to prevent over-transfusion.
Keywords: anemia; blood transfusion; hemoglobin; neonate; neonatology; packed red blood cell transfusion; preterm; red blood cell.
Copyright © 2025, Jena et al.
Conflict of interest statement
Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Institutional Ethics Committee, Kalinga Institute of Medical Sciences issued approval KIIT/KIMS/IEC/869/2022. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Similar articles
-
Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004863. doi: 10.1002/14651858.CD004863.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004863. doi: 10.1002/14651858.CD004863.pub3. PMID: 16856062 Updated.
-
Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004868. doi: 10.1002/14651858.CD004868.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004868. doi: 10.1002/14651858.CD004868.pub3. PMID: 16856064 Updated.
-
Strategies for cessation of caffeine administration in preterm infants.Cochrane Database Syst Rev. 2024 Jul 24;7(7):CD015802. doi: 10.1002/14651858.CD015802.pub2. Cochrane Database Syst Rev. 2024. PMID: 39045901 Free PMC article. Review.
-
Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.Cochrane Database Syst Rev. 2024 May 23;5(5):CD011305. doi: 10.1002/14651858.CD011305.pub3. Cochrane Database Syst Rev. 2024. PMID: 38780066 Free PMC article.
-
Transfusion thresholds for guiding red blood cell transfusion.Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD002042. doi: 10.1002/14651858.CD002042.pub5. Cochrane Database Syst Rev. 2021. PMID: 34932836 Free PMC article.
References
-
- Packed red blood cell transfusion in preterm infants. Bellach L, Eigenschink M, Hassanein A, et al. Lancet Haematol. 2022;9:615–626. - PubMed
-
- Guidelines on transfusion for fetuses, neonates and older children. New HV, Berryman J, Bolton-Maggs PH, et al. Br J Haematol. 2016;175:784–828. - PubMed
-
- Lau W. Canadian Blood Services, Clinical Guide to Transfusion. 2017. Chapter 13: neonatal and paediatrics transfusion.
-
- Module 6 Neonatal and Paediatrics: Patient Blood Management Guidelines. Australian National Blood Authority: Patient blood management guidelines: module 6 neonatal and paediatrics. 2016. https://www.blood.gov.au/module-6-neonatal-and-paediatrics-patient-blood... https://www.blood.gov.au/module-6-neonatal-and-paediatrics-patient-blood...
LinkOut - more resources
Full Text Sources